Palo Alto Investors »

Ptc Therapeutics I shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.8M 265k 37.10

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
United Therapeutics Corporation (UTHR)
Biogen Idec (BIIB)
Staar Surgical Com Par $0.01 (STAA)
ACADIA Pharmaceuticals (ACAD)
Alnylam Pharmaceuticals (ALNY)
Prothena Corp SHS (PRTA)
Iovance Biotherapeutics (IOVA)
Anaptysbio Inc Common (ANAB)
Sarepta Therapeutics (SRPT)
Alkermes SHS (ALKS)
Ptc Therapeutics I (PTCT)
Align Technology (ALGN)

View all positions for Palo Alto Investors

Top funds holding Ptc Therapeutics I

Vanguard Group
BlackRock
BlackRock
Armistice Capital
Cowen And Company
Henderson Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Jacobs Levy Equity Management
D. E. Shaw & Co
Franklin Resources
Blackstone Group
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Ptc Therapeutics I